Neogen® Launches Improved Quantitative ELISA Test for Peanuts
New test provides improved detection of high-priority peanut allergen in a wide variety of matrices
LANSING, Mich., May 18, 2022 /PRNewswire/ — Neogen® Corporation (NASDAQ: NEOG) today announced the release of an improved version of Veratox® for peanut allergen testing, which maximizes sensitivity and flexibility between sample types while maintaining the fast and simple testing procedure standards defined by the Veratox product line.
Neogen’s new Veratox VIP (Veratox Improvement Platform) for Peanut Assay is able to quickly quantify low levels of peanut protein residues in food products, ingredients and clean-in-place rinses.
“As the demand for plant-based foods continues to rise, we have seen peanut protein being processed in more new and creative ways than ever before. However, peanut remains one of the most priorities of the food industry,” said John Adent, President and CEO of Neogen. “It was very important that we offered a solution that gave growers confidence as they navigated this changing landscape. The new Veratox VIP for Peanut test is highly sensitive and capable of detecting low levels of peanut protein while remaining quick and easy to use.
This innovative quantitative test uses the combination of a unique antibody combination and a modified extraction process to robustly detect peanut protein levels down to 0.25 ppm. This product has been validated in a wide variety of product types, including minimally or more processed products. This flexibility makes the test suitable in different food manufacturing and laboratory environments.
Neogen Corporation develops and markets comprehensive solutions dedicated to food and animal safety, operating with the intention of “every day, protecting the people and animals we care about”. The Company’s Food Safety segment markets dehydrated culture media and diagnostic test kits for detecting foodborne bacteria, natural toxins, food allergens, drug residues, plant diseases and pests. sanitation problems. Neogen’s Animal Safety segment is a leader in the development of genomics solutions as well as the manufacturing and distribution of a variety of animal health products, including diagnostics, pharmaceuticals, veterinary instruments, wound care and disinfectants, as well as rodent and insect control solutions.
CONTACT: Wolf Maxproduct manager, 800-234-5333, [email protected]
SOURCE NEOGEN Corporation